The inhibition of gadolinium ion (Gd3+) on the mitochondrial F1FO-ATPase is linked to the modulation of the mitochondrial permeability transition pore

The mitochondrial permeability transition pore (PTP), which drives regulated cell death when Ca²⁺ concentration suddenly increases in mitochondria, was related to changes in the Ca²⁺-activated F₁F_O-ATPase. The effects of the gadolinium cation (Gd³⁺), widely used for diagnosis and therapy, and reported as PTP blocker, were evaluated on the F₁F_O-ATPase activated by Mg²⁺ or Ca²⁺ and on the PTP. Gd³⁺ more effectively inhibits the Ca²⁺-activated F₁F_O-ATPase than the Mg²⁺-activated F₁F_O-ATPase by a mixed-type inhibition on the former and by uncompetitive mechanism on the latter. Most likely Gd³⁺ binding to F₁, is favoured by Ca²⁺ insertion. The maximal inactivation rates (k_inact) of pseudo-first order inactivation are similar either when the F₁F_O-ATPase is activated by Ca²⁺ or by Mg²⁺. The half-maximal inactivator concentrations (K_I) are 2.35 ± 0.35 mM and 0.72 ± 0.11 mM, respectively. The potency of a mechanism-based inhibitor (k_inact/K_I) also highlights a higher inhibition efficiency of Gd³⁺ on the Ca²⁺-activated F₁F_O-ATPase (0.59 ± 0.09 mM^-1∙s^-1) than on the Mg²⁺-activated F₁F_O-ATPase (0.13 ± 0.02 mM^-1∙s^-1). Consistently, the PTP is desensitized in presence of Gd³⁺. The Gd³⁺ inhibition on both the mitochondrial Ca²⁺-activated F₁F_O-ATPase and the PTP strengthens the link between the PTP and the F₁F_O-ATPase when activated by Ca²⁺ and provides insights on the biological effects of Gd³⁺.

Effects of Humic Acids in Chronic Lead Poisoning

Chronic exposure to lead causes disruption to energy production mechanisms and tissue damage, in particular through its binding to thiol groups and competition for zinc binding sites. We investigated the possibility of preventing the consequences of chronic lead poisoning by administration of three different doses of humic acids (HAs) into feed with the aim of establishing an effective HA dose. During the 10-week experiment, a sub-lethal dose of lead acetate was given to rats during the first 5 weeks, with continuous administration of HA over 10 weeks. Measurements were taken to determine the content of the metals Pb, Mn, Cu, Fe and Zn; the metalloid Se; and selected antioxidant markers in the heart, liver, kidney and plasma after the first, fifth and tenth weeks of experiment. The administration of lead and HAs clearly affects the redistribution of the elements and the activity of the antioxidant enzymes. This fact was particularly highlighted in the lead-only group as, within the experiment, significantly higher Pb concentrations were found only in the plasma of this group. However, in the group with 1% HA administered with lead, we observed a rise in Zn concentrations in the organs and the deposition of Fe into the liver. Decreased glutathione reductase activity in the plasma and balanced reduced glutathione concentrations indicated sufficient efficiency of redox reactions. SOD activities were among those affected most strongly, with only the 1% HA group showing no effect on heavy metal redistribution as a result of HA administration.